User profiles for Dina Greene

Dina Greene

University of Washington
Verified email at uw.edu
Cited by 2738

Clinical laboratory practice recommendations for the use of cardiac troponin in acute coronary syndrome: expert opinion from the Academy of the American …

AHB Wu, RH Christenson, DN Greene… - Clinical …, 2018 - academic.oup.com
This document is an essential companion to the third iteration of the National Academy of
Clinical Biochemistry [NACB, 8 now the American Association for Clinical Chemistry (AACC) …

Acquisition of the L452R mutation in the ACE2-binding interface of Spike protein triggers recent massive expansion of SARS-Cov-2 variants

…, H Geng, C Fowler, D Greene… - Journal of clinical …, 2021 - Am Soc Microbiol
We report that there is a recent global expansion of numerous independent severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with mutation L452R in the receptor…

Directed evolution of RuBisCO hypermorphs through genetic selection in engineered E.coli

MR Parikh, DN Greene, KK Woods… - … Design and Selection, 2006 - academic.oup.com
The Calvin Cycle is the primary conduit for the fixation of carbon dioxide into the biosphere;
ribulose 1,5-bisphosphate carboxylase/oxygenase (RuBisCO) catalyzes the rate-limiting …

α1-Antitrypsin phenotypes and associated serum protein concentrations in a large clinical population

JA Bornhorst, DN Greene, ER Ashwood, DG Grenache - Chest, 2013 - Elsevier
Background α 1 -Antitrypsin (AAT) deficiency variants reduce the concentration of serum
AAT protease inhibitor and can lead to the development of pulmonary and hepatic disease. …

When gender identity doesn't equal sex recorded at birth: the role of the laboratory in providing effective healthcare to the transgender community

Z Goldstein, TA Corneil, DN Greene - Clinical chemistry, 2017 - academic.oup.com
BACKGROUND Transgender is an umbrella term used to describe individuals who identify
with a gender incongruent to or variant from their sex recorded at birth. Affirming gender …

Advances in detection of hemoglobinopathies

DN Greene, CP Vaughn, BO Crews, AM Agarwal - Clinica chimica acta, 2015 - Elsevier
Hemoglobin disorders are recognized as one of the most common inherited diseases worldwide.
Detecting and characterizing variant hemoglobins and thalassemias depends primarily …

Biotin interference in clinical immunoassays

PJ Colon, DN Greene - The Journal of Applied Laboratory …, 2018 - academic.oup.com
Background Shifts in consumer behavior and clinical practice have increased reports of biotin
interference in immunoassays that incorporate biotin–streptavidin linkages in their design. …

Variability and error in cardiac troponin testing: an ACLPS critical review

…, PA Kavsak, DN Greene - American Journal of …, 2017 - academic.oup.com
Objectives To provide a comprehensive overview of the complexities associated with cardiac
troponin (cTn) testing. An emphasis is placed on the sources of error, organized into the …

Artificially evolved Synechococcus PCC6301 Rubisco variants exhibit improvements in folding and catalytic efficiency

DN Greene, SM Whitney, I Matsumura - Biochemical Journal, 2007 - portlandpress.com
The photosynthetic CO 2 -fixing enzyme, Rubisco (ribulose-1,5-bisphosphate carboxylase/oxygenase),
is responsible for most of the world's biomass, but is a slow non-specific catalyst. …

Comparison of Sebia Capillarys Flex capillary electrophoresis with the BioRad Variant II high pressure liquid chromatography in the evaluation of hemoglobinopathies

DN Greene, AL Pyle, JS Chang, C Hoke, T Lorey - Clinica Chimica Acta, 2012 - Elsevier
BACKGROUND: There are multiple biochemical screening techniques for assessing
hemoglobinopathies. Here we compare a new instrument, the Sebia Capillarys Flex (capillary zone …